ICure Pharm Inc.
ICure Pharm Inc. operates in Soft Drinks & Non-alcoholic Beverages.
Market Cap & Net Worth: ICure Pharm Inc. (175250)
ICure Pharm Inc. (KO:175250) has a market capitalization of $14.68K (₩21.49 Million) as of March 18, 2026. Listed on the KO stock exchange, this Korea-based company holds position #44415 globally and #2530 in its home market, demonstrating a 8.77% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying ICure Pharm Inc.'s stock price ₩2170.00 by its total outstanding shares 9904 (9.90K).
ICure Pharm Inc. Market Cap History: 2018 to 2025
ICure Pharm Inc.'s market capitalization history from 2018 to 2025. Data shows change from $66.73K to $14.68K (-25.42% CAGR).
ICure Pharm Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how ICure Pharm Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 175250 by Market Capitalization
Companies near ICure Pharm Inc. in the global market cap rankings as of March 18, 2026.
Key companies related to ICure Pharm Inc. by market ranking:
- Bifido Co. Ltd. (KO:238200): Ranked #43977 globally with a market cap of $18.50K USD ( ₩27.08 Million KRW).
- KMPharmaceutical Co. Ltd. (KO:225430): Ranked #46967 globally with a market cap of $2.52K USD ( ₩3.69 Million KRW).
- LTHP (LSE:LTHP): Ranked #44406 globally with a market cap of $14.13K USD ( £11.55K GBP).
- REALORD GROUP HLDGS (CUV.SG) (STU:CUV): Ranked #44416 globally with a market cap of $14.04K USD ( €13.68K EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #43977 | Bifido Co. Ltd. | KO:238200 | $18.50K | ₩2925.00 |
| #46967 | KMPharmaceutical Co. Ltd. | KO:225430 | $2.52K | ₩408.00 |
| #44406 | LTHP | LSE:LTHP | $14.13K | £1.23 |
| #44416 | REALORD GROUP HLDGS (CUV.SG) | STU:CUV | $14.04K | €1.50 |
ICure Pharm Inc. Historical Marketcap From 2018 to 2025
Between 2018 and today, ICure Pharm Inc.'s market cap moved from $66.73K to $ 14.68K, with a yearly change of -25.42%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | ₩14.68K | +19.56% |
| 2024 | ₩12.28K | -13.16% |
| 2023 | ₩14.14K | -18.20% |
| 2022 | ₩17.28K | -80.40% |
| 2021 | ₩88.19K | -30.67% |
| 2020 | ₩127.20K | +74.27% |
| 2019 | ₩72.99K | +9.38% |
| 2018 | ₩66.73K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of ICure Pharm Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $14.68K USD |
| MoneyControl | $14.68K USD |
| MarketWatch | $14.68K USD |
| marketcap.company | $14.68K USD |
| Reuters | $14.68K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.